A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. (Q33358107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Jonathan C Trent

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jennifer Beach

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Michael A Burgess

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Nicholas Papadopolous

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Robert S Benjamin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Shreyaskumar R Patel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2693-2699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669291%20AND%20SRC:MED&resulttype=core&format=json

Interstitial cells of Cajal: pacemaker cells?

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

21 January 2018

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11875

7 January 2021